RxDoctor Payments Data

Arpita Devani

Internal Medicine · Los Angeles, CANPI 1962604124

Payments from drug & device makers

$35,245in general payments, 2019–2025

Across 443 payments — averaging $79.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$29K
  • AbbVie$6K
  • Merz North America, Inc.$551
  • Revance Therapeutics, Inc.$88

What the payments were for

  • Speaking & faculty fees$25,50072%
  • Travel & lodging$7152%
  • Food & beverage$9,00826%
  • Education$230%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Galderma Laboratories, L.p.170$29,105
AbbVie(2 entities)265$5,501
Merz North America, Inc.7$551
Revance Therapeutics, Inc.1$88

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,245 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Other internal medicine in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →